The highest dose produced weight loss comparable to liraglutide 3.0 mg, establishing cagrilintide as the first long-acting amylin analog to demonstrate clinically meaningful weight reduction in a randomized trial
GLP-1 Only: Pharmacological and Clinical Comparison The following framework outlines key differences between tirzepatide and single-action GLP-1 medications, helping clarify why dual-receptor activation may suit some patients better than others based on clinical history and metabolic goals
In trials, average results were strong, but people did not all lose the same amount of weight or get the same level of glucose improvement
Switching recommendations for patients taking OZEMPIC 0.25 mg, 1 mg or 2 mg subcutaneously once weekly to RYBELSUS (formulation R1) are not available
A.CerquaC.CassinaM.TrevissonE.SalviatiL
There have been reports of patients mistakenly dialing the pen to the maximum dose, which has resulted in calls to poison centers for help